Aarti Drugs shares surge over 16% on buyback approval

Aarti Drugs’s stock witnessed a significant rise of 16.30% after the company’s board approved a buyback of shares at ₹900 per share, representing 0.72% of the existing paid-up capital. Read More | Source: The Hindu Business Line